Should You Buy Allarity Therapeutics Inc (ALLR) Today? Analysis, Price Targets, and 2026 Outlook.
Analysis Updated At
2026/01/28
ALLR is not a good buy right now for a Beginner, long-term investor with $50,000–$100,000. The stock has no clear technical breakout, no proprietary buy signals, no recent news catalysts, and fundamentals remain weak (no revenue and widening losses). If you already own it, this is a HOLD at best; for a new long-term position, I would pass today.
Technical Analysis
Pre-market price is ~1.19, sitting near the pivot level (1.183). Momentum is mildly positive but not strong: MACD histogram is above zero (0.0064) but positively contracting, which often signals fading upside momentum rather than a fresh uptrend. RSI(6) at 56.04 is neutral (no overbought/oversold edge). Moving averages are converging, suggesting consolidation rather than a decisive trend. Key levels: support S1 1.116 then S2 1.075; resistance R1 1.25 then R2 1.291. A clean move and hold above ~1.25 would improve the technical picture, but at current levels the setup is more “range-bound/uncertain” than “strong uptrend.”